Effects of Timing of Cord Clamping on Serum Calcium Levels in Neonates
NCT ID: NCT06573333
Last Updated: 2024-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2024-01-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: The objective is to determine the effects of early and delayed cord on serum calcium level in neonates Study Design: Randomized Controlled Trial
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Timing of Umbilical Cord Clamping in Preterm Neonates
NCT06000800
Hemodynamic Effects of Delayed Umbilical Cord Clamping in Full-term Newborns
NCT04358822
Association Between Blood Volume, the Interval From Delivery to Cord Clamping, and Number of Umbilical Cord Milking
NCT04898868
Effect of Intact Umbilical Cord Milking on Neonatal and First Year Neurodevelopmental Outcomes in Very Preterm Infants.
NCT03200301
Immediate VS Delayed Cord Clamping on Newborns
NCT01029496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients and Methods: Total sample size of 200 neonates will be included in the study divided into four groups with cord clamping at 15s, 30s, 60s, 120s each group will have a total of 50 neonates. Blood sampling for CBC / CRP / S. Electrolytes (Na, K, Total Ca, Ionized Ca, Mg), S Calcitonin, ABGs (HCO3 Levels) samples will be collected at 6 hours of life.
* Inclusion Criteria: Neonates born at gestational age 37 weeks to 41 weeks with no maternal complication. Parents who give consent for inclusion in the study
* Exclusion Criteria: Mothers with evidence of clinical disease (diabetes, preeclampsia, hypertension). Babies with congenital malformations and intrauterine growth restriction.
Expected Results: Research data on serum Calcium levels in neonates have shown no correlation to timing of cord clamping. Same results are expected in this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
15 seconds
Umbilical Cord will be clamped after 15s of birth and Serum calcium levels will be measured at 6 hours of life
Umblical Cord Clamping
Umbilical Cord will be clamped using a plastic clamp at the noted time after delivery of the neonate
30seconds
Umbilical Cord will be clamped after 30s of birth and Serum calcium levels will be measured at 6 hours of life
Umblical Cord Clamping
Umbilical Cord will be clamped using a plastic clamp at the noted time after delivery of the neonate
60seconds
Umbilical Cord will be clamped after 60s of birth and Serum calcium levels will be measured at 6 hours of life
Umblical Cord Clamping
Umbilical Cord will be clamped using a plastic clamp at the noted time after delivery of the neonate
120 seconds
Umbilical Cord will be clamped after 120s of birth and Serum calcium levels will be measured at 6 hours of life
Umblical Cord Clamping
Umbilical Cord will be clamped using a plastic clamp at the noted time after delivery of the neonate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Umblical Cord Clamping
Umbilical Cord will be clamped using a plastic clamp at the noted time after delivery of the neonate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Minute
6 Hours
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
College of Physicians and Surgeons Pakistan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Umair Anees Qureshi
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arshad Khushdil, MBBS
Role: PRINCIPAL_INVESTIGATOR
Military Hospital Rawalpindi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pak Emirates Military Hospital
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
369452
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.